PTX 0.00% 4.0¢ prescient therapeutics limited

Daily happenings?., page-351

  1. 250 Posts.
    lightbulb Created with Sketch. 84
    Has anyone thoughts on how the CellPryme assett will be converted to revenue. How do you quantify a charge to 3rd parties under a licensing agreement. Upfront license fee and then a royalty?? fee. Any stabs at quantifying this revenue stream
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.